RNLS and COVID-19: Taken together, renalase feasible ability to in vitro and in vivo reduces clinical perils by the reduction of ROS, inflammation, apoptosis, necrosis, and toxic catecholamine effects, which may be a brand new approach to battle COVID-19-induced cytokine storm and its detrimental consequences.